HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

VaxSyn HIV-1 (gp160) vaccine

HIV vaccine approved for clinical trial; a recombinant form of the HIV envelope protein gp160; coordinate with HIV envelope protein gp160(NM)
Also Known As:
MicroGeneSys HIV-1 gp160 vaccine; VaxSyn HIV-1 (gp160); immuno rgp 160; rgp 160; rgp160
Networked: 28 relevant articles (1 outcomes, 9 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Poncelet, Hubert: 1 article (11/2008)
2. Silbermann, Benjamin: 1 article (11/2008)
3. Launay, Odile: 1 article (11/2008)
4. Petitprez, Karine: 1 article (11/2008)
5. Desaint, Corinne: 1 article (11/2008)
6. Pialoux, Gilles: 1 article (11/2008)
7. Slama, Laurence: 1 article (11/2008)
8. Mazarin, Veronique: 1 article (11/2008)
9. Moreau, Corinne: 1 article (11/2008)
10. Salmon-Ceron, Dominique: 1 article (11/2008)

Related Diseases

1. Disease Progression
2. Vaccinia
3. HIV Infections (HIV Infection)
4. Acquired Immunodeficiency Syndrome (AIDS)
5. Hypersensitivity (Allergy)

Related Drugs and Biologics

1. Glycoproteins (Glycoprotein)
2. Antibodies
3. Neutralizing Antibodies
4. Antigens
5. Staphylococcal Protein A (A, Protein)
6. Recombinant Proteins
7. Antibody Binding Sites
8. AIDSVAX
9. lentil lectin

Related Therapies and Procedures

1. Injections